BACKGROUND: Feline idiopathic cystitis (FIC) is a common lower urinary tract disorder of domestic cats that resembles interstitial cystitis/painful bladder syndrome (IC/PBS) in humans. Diagnosis of FIC is based on clinical signs and exclusion of other disorders because of a lack of specific pathologic findings or other objective biomarkers. Cytokines are potential noninvasive biomarkers to define the presence, severity, and progression of disease, and response to treatment.
OBJECTIVES: The objective of this pilot study was to determine concentrations of selected cytokines in serum from healthy cats and cats with acute FIC.
ANIMALS: Serum samples from 13 healthy cats and from 12 cats with nonobstructive acute FIC were utilized.
METHODS: Multiplex analysis of 19 cytokines (CCL2, CCL5, CXCL1, CXCL12, CXCL8, Flt3L, GM-CSF, IFN-γ, IL-12 (p40), IL-13, IL-18, IL-1β, IL-2, IL-4, IL-6, PDGF-BB, SCF, sFas, and TNF-α) was performed with a commercially available feline-specific multiplex bead-based assay.
RESULTS: Mean serum concentrations of IL-12 (p40; P < 0.0001), CXCL12 (P = 0.002), IL-18 (P = 0.032), and Flt3L (P = 0.0024) were significantly increased in FIC cats compared to healthy cats. GM-CSF, IL-1b, IL-2, and PDGF-BB were undetectable or detected in an insufficient number of cats to allow meaningful comparisons.
CONCLUSIONS AND CLINICAL IMPORTANCE: We have identified increased serum concentrations of pro-inflammatory cytokines and chemokines CXCL12, IL-12, IL-18, and Flt3L in FIC-affected cats. These findings suggest potential candidates for noninvasive biomarkers for diagnosis, staging, and therapeutic outcome monitoring of affected cats and provide additional insight into the etiopathogenesis of FIC.
Am J Vet Res. 2011 Oct;72(10):1407-15
[PMID:
21962285]
Am J Vet Res. 2016 May;77(5):495-504
[PMID:
27111017]
Vet Rec. 1979 Sep 15;105(11):243-7
[PMID:
516298]
Blood. 2004 Jun 15;103(12):4619-21
[PMID:
15001472]
Leukemia. 2000 Jan;14(1):153-62
[PMID:
10637491]
J Immunol. 2000 May 1;164(9):4752-61
[PMID:
10779781]
Nat Immunol. 2008 Jun;9(6):676-83
[PMID:
18469816]
PLoS One. 2013;8(1):e54884
[PMID:
23349985]
Nat Rev Immunol. 2003 Feb;3(2):133-46
[PMID:
12563297]
Analyst. 2009 Jun;134(6):1133-7
[PMID:
19475139]
J Am Vet Med Assoc. 1991 Jul 15;199(2):211-6
[PMID:
1653776]
PLoS One. 2013 Nov 21;8(11):e79751
[PMID:
24278169]
BJU Int. 2011 Feb;107(4):670-7
[PMID:
20636394]
J Vet Intern Med. 1990 Mar-Apr;4(2):71-8
[PMID:
2187983]
J Vet Intern Med. 2000 Nov-Dec;14(6):593-7
[PMID:
11110380]
J Immunol. 2000 Jan 1;164(1):64-71
[PMID:
10604994]
J Urol. 2002 Jun;167(6):2461-9
[PMID:
11992058]
J Vet Intern Med. 2011 Mar-Apr;25(2):199-205
[PMID:
21314728]
J Immunol. 2012 Feb 1;188(3):1125-35
[PMID:
22198954]
PLoS One. 2012;7(12):e51391
[PMID:
23236492]
N Engl J Med. 1998 Feb 12;338(7):436-45
[PMID:
9459648]
J Small Anim Pract. 2005 Dec;46(12):571-7
[PMID:
16355731]
J Vet Intern Med. 2011 Jul-Aug;25(4):784-96
[PMID:
21564297]
J Immunol. 2002 Feb 1;168(3):1146-53
[PMID:
11801649]
PLoS One. 2011 Feb 16;6(2):e14698
[PMID:
21359206]
World J Urol. 2013 Feb;31(1):241-6
[PMID:
22441309]
J Am Vet Med Assoc. 1971 Jan 15;158(2):200-1
[PMID:
4993553]
Arthritis Res Ther. 2013;15(6):R209
[PMID:
24314260]
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16741-6
[PMID:
16272221]
Blood. 2000 Jun 1;95(11):3489-97
[PMID:
10828034]
Int Urol Nephrol. 2010 Sep;42(3):629-35
[PMID:
19784793]
J Urol. 2014 Nov;192(5):1564-8
[PMID:
24813342]
Stem Cells Dev. 2017 May 15;26(10 ):776-785
[PMID:
28181858]
Blood. 1996 Sep 15;88(6):2004-12
[PMID:
8822919]
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9759-64
[PMID:
20457904]
Autoimmun Rev. 2014 Feb;13(2):117-24
[PMID:
24113138]
J Immunother. 2003 Jul-Aug;26(4):343-8
[PMID:
12843796]
Vet Clin North Am Small Anim Pract. 2009 Jan;39(1):15-40
[PMID:
19038648]
Eur J Immunol. 1997 Jul;27(7):1788-93
[PMID:
9247593]
Vet J. 2013 Dec;198(3):625-30
[PMID:
24257070]
Pain. 2014 Sep;155(9):1755-61
[PMID:
24907404]
J Exp Med. 1997 Jan 6;185(1):111-20
[PMID:
8996247]
J Neurosci. 2001 Jul 15;21(14):5027-35
[PMID:
11438578]
